The pharmaceutical landscape for blood sugar is shifting, and GLP-1 patches represent a promising development. Unlike shots, this approach offers a less invasive way to deliver GLP-1 drugs. These devices steadily release the drug through the epidermis offering a even amount of the active agent, which can improve glucose control and possibly decreas